Learn about the process, risks, monitoring needs, and potential side effects of CAR T-cell therapy treatment of hematologic malignancies, with an emphasis on patient and family education. An interactive scenario and supporting resources reinforce learning.
You will enjoy access for 90 days from date of purchase, after which you will no longer be able to access the course.
This resource was developed by ONS through a sponsorship from Janssen Oncology. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.